[Treatment of hemorrhage from acute gastric and duodenal mucosa lesions with secretin].
In a prospective study 67 patients with bleeding from acute gastric mucosal lesions were treated by intravenous infusion of secretin. In 64 of the 67 patients bleeding stopped during secretin infusion. In 16 of these 64, bleeding recurred after cessation of the secretin infusion; all recurrences were stopped by secretin. Severe side effects were not observed. Secretin seems to be an effective drug in the treatment of stress ulcer bleeding.
D000328:Adult; D002986:Clinical Trials as Topic; D004381:Duodenal Ulcer / Q000150:complications / Q000188:drug therapy*; D005260:Female; D005753:Gastric Mucosa; D006801:Humans; D007413:Intestinal Mucosa; D008297:Male; D010438:Peptic Ulcer Hemorrhage / Q000188:drug therapy*; D011446:Prospective Studies; D012633:Secretin / Q000008:administration & dosage*; D013276:Stomach Ulcer / Q000150:complications / Q000188:drug therapy*
D012633:Secretin
Die Behandlung der Blutung aus akuten Schleimhautläsionen des Magens und Duodenums durch Secretin.